Largest biotech companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Amgen leads the 24 biotech companies ranked by total assets, at SEK 921.4B, ahead of Gilead Sciences (SEK 600.4B) and Biogen (SEK 299.5B). Figures as of 18 Nov 2026, 19:33 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- AmgenSEK 921.4B
- Median
- SEK 26B
- Combined market value
- SEK 8.5T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | SEK 921.4B | SEK 2.44T | SEK 4,503.57 | 3.32% down | 34% up | ||
| 2 | Gilead SciencesGILD · Health Care | SEK 600.4B | SEK 2.12T | SEK 1,712.06 | 1.15% down | 33% up | ||
| 3 | BiogenBIIB · Health Care | SEK 299.5B | SEK 376B | SEK 2,543.72 | 0.29% down | 49% up | ||
| 4 | BioNTechBNTX · Health Care | SEK 248.2B | SEK 210.5B | SEK 848.96 | 1.65% down | 16% down | ||
| 5 | ModernaMRNA · Health Care | SEK 125.5B | SEK 816.1B | SEK 2,016.86 | 4.12% down | 755% up | ||
| 6 | argenxARGX · Health Care | SEK 88.3B | SEK 603.3B | SEK 9,594.12 | 0.46% down | 4% up | ||
| 7 | QiagenQGEN · Health Care | SEK 63.9B | SEK 104.2B | SEK 504.69 | 0.27% down | 12% up | ||
| 8 | Neurocrine BiosciencesNBIX · Health Care | SEK 47.1B | SEK 168.1B | SEK 1,660.74 | 1.60% down | 20% up | ||
| 9 | VaxcytePCVX · Health Care | SEK 30.5B | SEK 93.9B | SEK 593.03 | 1.85% down | 22% up | ||
| 10 | RepligenRGEN · Health Care | SEK 30B | SEK 111.2B | SEK 1,739.73 | 5.46% up | 5% up | ||
| 11 | ExelixisEXEL · Health Care | SEK 28.9B | SEK 170.1B | SEK 697.04 | 0.04% up | 63% up | ||
| 12 | Bio-TechneTECH · Health Care | SEK 26.3B | SEK 116.3B | SEK 740.32 | 0.21% up | 26% up | ||
| 13 | Halozyme TherapeuticsHALO · Health Care | SEK 25.7B | SEK 111.5B | SEK 978.04 | 0.19% up | 37% up | ||
| 14 | Revolution MedicinesRVMD · Health Care | SEK 24B | SEK 352.8B | SEK 1,631.09 | 1.44% down | 131% up | ||
| 15 | CRISPR TherapeuticsCRSP · Health Care | SEK 23B | SEK 40.4B | SEK 416.55 | 1.99% up | 21% down | ||
| 16 | Kymera TherapeuticsKYMR · Health Care | SEK 17.7B | SEK 105.3B | SEK 1,233.62 | 0.20% down | 87% up | ||
| 17 | Krystal BiotechKRYS · Health Care | SEK 13.6B | SEK 94.4B | SEK 3,185.12 | 4.88% up | 46% up | ||
| 18 | ImmunovantIMVT · Health Care | SEK 9.7B | SEK 70B | SEK 338.22 | 0.12% up | 43% up | ||
| 19 | CG OncologyCGON · Health Care | SEK 8.1B | SEK 72.1B | SEK 806.75 | 0.47% up | 85% up | ||
| 20 | Twist BioscienceTWST · Health Care | SEK 6.5B | SEK 82B | SEK 1,203.46 | 5.63% up | 340% up | ||
| 21 | Adaptive BiotechnologiesADPT · Health Care | SEK 5.2B | SEK 46.9B | SEK 289.70 | 0.04% down | 88% up | ||
| 22 | ImmunityBioIBRX · Health Care | SEK 5.1B | SEK 72.8B | SEK 68.46 | 7.51% up | 193% up | ||
| 23 | Scholar Rock HoldingSRRK · Health Care | SEK 4.1B | SEK 58.9B | SEK 483.17 | 5.37% up | 14% up | ||
| 24 | Kodiak SciencesKOD · Health Care | SEK 3.6B | SEK 64.3B | SEK 983.38 | 0.13% down | 396% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1721 SEK).
Questions and answers
Which biotech companies rank first by total assets?
Amgen (SEK 921.4B), Gilead Sciences (SEK 600.4B) and Biogen (SEK 299.5B) are the top three of the 24 biotech companies ranked by total assets as of 18 Nov 2026, 19:33 UTC.
How many biotech companies are in this ranking?
24 are ranked by total assets.
What are these biotech companies worth together?
The 24 biotech companies ranked by total assets have a combined market value of SEK 8.5T as of 18 Nov 2026, 19:33 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech companies by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.